• Trials and Research

  Long-Term Gilenya in Relapsing MS Patients Safe, Effective, Trial Shows

  Posted by MS News Today Moderator on October 28, 2019 at 12:30 pm

  

  Long-term treatment with Gilenya (fingolimod) in patients with relapsing forms of multiple sclerosis (MS) is safe and effective, a Phase 3 trial shows. Read more about it here.

  Have you heard of this news? What are your thoughts about these results?

  MS News Today Moderator replied 4 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply